255 related articles for article (PubMed ID: 17068821)
1. Chronic inhaled corticosteroids do not affect the course of acute severe asthma exacerbations in children.
Carroll CL; Bhandari A; Schramm CM; Zucker AR
Pediatr Pulmonol; 2006 Dec; 41(12):1213-7. PubMed ID: 17068821
[TBL] [Abstract][Full Text] [Related]
2. Childhood obesity increases duration of therapy during severe asthma exacerbations.
Carroll CL; Bhandari A; Zucker AR; Schramm CM
Pediatr Crit Care Med; 2006 Nov; 7(6):527-31. PubMed ID: 17006390
[TBL] [Abstract][Full Text] [Related]
3. Slow-responders to IV beta2-adrenergic agonist therapy: defining a novel phenotype in pediatric asthma.
Carroll CL; Schramm CM; Zucker AR
Pediatr Pulmonol; 2008 Jul; 43(7):627-33. PubMed ID: 18500733
[TBL] [Abstract][Full Text] [Related]
4. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial.
Wheeler DS; Jacobs BR; Kenreigh CA; Bean JA; Hutson TK; Brilli RJ
Pediatr Crit Care Med; 2005 Mar; 6(2):142-7. PubMed ID: 15730599
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptor polymorphisms associated with length of ICU stay in pediatric status asthmaticus.
Carroll CL; Sala KA; Zucker AR; Schramm CM
Pediatr Pulmonol; 2012 Mar; 47(3):233-9. PubMed ID: 21905268
[TBL] [Abstract][Full Text] [Related]
6. Identifying an at-risk population of children with recurrent near-fatal asthma exacerbations.
Carroll CL; Uygungil B; Zucker AR; Schramm CM
J Asthma; 2010 May; 47(4):460-4. PubMed ID: 20528602
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
[TBL] [Abstract][Full Text] [Related]
8. Protocol-based titration of intravenous terbutaline decreases length of stay in pediatric status asthmaticus.
Carroll CL; Schramm CM
Pediatr Pulmonol; 2006 Apr; 41(4):350-6. PubMed ID: 16502398
[TBL] [Abstract][Full Text] [Related]
9. Pediatric asthma admissions: chronic severity and acute exacerbations.
Elizur A; Bacharier LB; Strunk RC
J Asthma; 2007 May; 44(4):285-9. PubMed ID: 17530527
[TBL] [Abstract][Full Text] [Related]
10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
11. Severe exacerbations in children with mild asthma: characterizing a pediatric phenotype.
Carroll CL; Schramm CM; Zucker AR
J Asthma; 2008 Aug; 45(6):513-7. PubMed ID: 18612906
[TBL] [Abstract][Full Text] [Related]
12. Barotrauma not related to type of positive pressure ventilation during severe asthma exacerbations in children.
Carroll CL; Zucker AR
J Asthma; 2008 Jun; 45(5):421-4. PubMed ID: 18569237
[TBL] [Abstract][Full Text] [Related]
13. Endotracheal intubation and pediatric status asthmaticus: site of original care affects treatment.
Carroll CL; Smith SR; Collins MS; Bhandari A; Schramm CM; Zucker AR
Pediatr Crit Care Med; 2007 Mar; 8(2):91-5. PubMed ID: 17273123
[TBL] [Abstract][Full Text] [Related]
14. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for treatment of intermittent mild persistent asthma in children and adolescents.
Naspitz CK; Cropp GJ
Pediatr Pulmonol; 2009 Mar; 44(3):205-8. PubMed ID: 19206182
[TBL] [Abstract][Full Text] [Related]
16. The increased cost of complications in children with status asthmaticus.
Carroll CL; Zucker AR
Pediatr Pulmonol; 2007 Oct; 42(10):914-9. PubMed ID: 17726707
[TBL] [Abstract][Full Text] [Related]
17. Treatment with inhaled corticosteroids in asthma is too often discontinued.
Breekveldt-Postma NS; Koerselman J; Erkens JA; van der Molen T; Lammers JW; Herings RM;
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):411-22. PubMed ID: 18205251
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
19. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
20. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
